Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat

被引:22
作者
Brunner, F
Wölkart, G
Pfeiffer, S
Russell, JC
Wascher, TC
机构
[1] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, A-8010 Graz, Austria
[2] Univ Alberta, Dept Surg, Edmonton, AB, Canada
[3] Karl Franzens Univ Graz, Dept Internal Med, Diabet Angiopathy Res Grp, Graz, Austria
基金
奥地利科学基金会;
关键词
diabetes; endothelial function; microcirculation; nitric oxide; ventricular function;
D O I
10.1016/S0008-6363(00)00056-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The JCR:LA-corpulent rat is a unique animal model of human vascular disease that exhibits a profound insulin resistance, vasculopathy, and cardiovascular dysfunction. We tested the hypothesis that the defects affect endothelial and smooth muscle function of the coronary microvasculature as well as cardiac contractility. Coronary, myocardial and aortic function were assessed in obese (homozygous for the cp gene, cp/cp) and lean (heterozygous or homozygous normal, +/?) littermates aged 7 and 18 weeks. Methods: Coronary endothelial relaxation was examined in isolated perfused hearts by determining the effect of bradykinin (0.1-1000 nmol l(-1)) on coronary perfusion pressure (CPP), myocardial mechanical function was evaluated in terms of left-ventricular developed pressure (LVDevP), and aortic relaxation with the endothelium-dependent agonist, A 23187 (1-1000 nmol l(-1)). Results: In rats aged 7 weeks, bradykinin reduced CPP from 133+/-1 mmHg to 43+/-1 mmHg (-67%) in lean rats, but only to 64+/-3 mmHg (-52%) in corpulent rats (n=6, P<0.05). Similar differences were found in rats aged 18 weeks (n=8). Inhibition of NO synthase with N-G-nitro-L-arginine (L-NNA; 0.2 mmol l(-1)) impaired, and tetrahydrobiopterin (0.1 mmol l(-1)), a NO synthase cofactor, restored relaxation in cp/cp rats. Spermine/NO equally reduced CPP in both groups (-58%). Mechanical function was similar in lean and corpulent rats, aortic endothelial relaxation was attenuated by similar to 30% and aortic smooth muscle function was normal (7 weeks) or improved (18 weeks) in the cp/cp genotype. Conclusion: These results suggest that (i) there is a specific impairment of NO-mediated relaxation of the coronary resistance vessels in the JCR:LA-corpulent rat that is not associated with impaired baseline myocardial contractility, and (ii) exogenous tetrahydrobiopterin reversed the relaxation defects that are part of the vascular complications typical for the insulin resistance syndrome. (C) 2000 Elsevier Science BN. All rights reserved.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 34 条
[1]   The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo [J].
Absher, PM ;
Schneider, DJ ;
Baldor, LC ;
Russell, JC ;
Sobel, BE .
ATHEROSCLEROSIS, 1999, 143 (02) :245-251
[2]   Increased proliferation of explanted vascular smooth muscle cells: A marker presaging atherogenesis [J].
Absher, PM ;
Schneider, DJ ;
Baldor, LC ;
Russell, JC ;
Sobel, BE .
ATHEROSCLEROSIS, 1997, 131 (02) :187-194
[3]   Enzymatic function of nitric oxide synthases [J].
Andrew, PJ ;
Mayer, B .
CARDIOVASCULAR RESEARCH, 1999, 43 (03) :521-531
[4]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[5]   Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart [J].
Brunner, F ;
Leonhard, B ;
Kukovetz, WR ;
Mayer, B .
CARDIOVASCULAR RESEARCH, 1997, 36 (01) :60-66
[6]   NOVEL GUANYLYL CYCLASE INHIBITOR, ODQ REVEALS ROLE OF NITRIC-OXIDE, BUT NOT OF CYCLIC-GMP IN ENDOTHELIN-1 SECRETION [J].
BRUNNER, F ;
STESSEL, H ;
KUKOVETZ, WR .
FEBS LETTERS, 1995, 376 (03) :262-266
[7]   Type 2 diabetes: one disease, multiple cardiovascular risk factors [J].
Calles-Escandon, J ;
Garcia-Rubi, E ;
Mirza, S ;
Mortensen, A .
CORONARY ARTERY DISEASE, 1999, 10 (01) :23-30
[8]   Tetrahydrobiopterin and endothelial nitric oxide synthase activity [J].
Cosentino, F ;
Lüscher, TF .
CARDIOVASCULAR RESEARCH, 1999, 43 (02) :274-278
[9]   ENDOTHELIUM-DERIVED RELAXING AND CONTRACTING FACTORS [J].
FURCHGOTT, RF ;
VANHOUTTE, PM .
FASEB JOURNAL, 1989, 3 (09) :2007-2018
[10]   Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity [J].
Hogikyan, RV ;
Galecki, AT ;
Pitt, B ;
Halter, JB ;
Greene, DA ;
Supiano, MA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06) :1946-1952